The American Diabetes Association recommends annual screening of urinary albumin (spot urine albumin/creatinine ratio) and eGFR in patients who have had type 1 diabetes for at least five years, in all patients with type 2 diabetes beginning at the time of diagnosis, and in all patients who have comorbid hypertension [26]. This evidence concerns the gene ALB and type 2 diabetes mellitus.